Richard J. Barohn
Expertise in
20
conditions

Dr. Richard J. Barohn

Neurology
The Curators Of The University Of Missouri
1020 Hitt St, Neurology Clinic Univ Of M, 
Columbia, MO 
Accepting New Patients
Expertise in
20
conditions
The Curators Of The University Of Missouri
1020 Hitt St, Neurology Clinic Univ Of M, 
Columbia, MO 
OverviewInsuranceLocationsClinical ResearchSimilar Doctors

Overview

Richard Barohn is a Neurologist in Columbia, Missouri. Dr. Barohn is highly rated in 20 conditions, according to our data. His top areas of expertise are Inclusion Body Myositis, Myasthenia Gravis, Myositis, Amyotrophic Lateral Sclerosis (ALS or Lou Gehrig's Disease), and Thymectomy. Dr. Barohn is currently accepting new patients.

His clinical research consists of co-authoring 176 peer reviewed articles and participating in 9 clinical trials. MediFind looks at clinical research from the past 15 years.

Specialties
Neurology
Licenses
Psychiatry & Neurology in KS
Hospital Affiliations
University Of Missouri Health Care
Languages Spoken
English
Gender
Male

Insurance

Accepted insurance can change. Please verify directly with the provider.

Find your insurance
Find your insuranceClose

Accepted insurance plans:

Aetna
  • EPO
  • HMO
  • POS
  • PPO
Anthem
  • EPO
  • HMO
  • POS
  • PPO
Blue Cross Blue Shield
  • EPO
  • HMO
  • POS
  • PPO
Health Alliance
  • EPO
  • HMO
  • POS
  • PPO
Humana
  • HMO
  • INDEMNITY
  • POS
  • PPO
Medica
  • EPO
  • HMO
  • PPO
Medicaid
  • OTHER MEDICAID
  • STATE MEDICAID
Medicare
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • MEDICARE SNP
  • MEDICARE-MEDICAID PLAN
  • OTHER MEDICARE PART D
UnitedHealthcare
  • EPO
  • HMO
  • POS
  • PPO
View 4 Less Insurance Carriers -

Locations

THE CURATORS OF THE UNIVERSITY OF MISSOURI
1020 Hitt St, Neurology Clinic Univ Of M, Columbia, MO 65212

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Providers who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

9 Clinical Trials

Phenotype, Genotype & Biomarkers in ALS and Related Disorders
Phenotype, Genotype & Biomarkers in ALS and Related Disorders
Enrollment Status: Enrolling_by_invitation
Publish Date: July 03, 2025
Phase 2B Study of Memantine for the Treatment of Amyotrophic Lateral Sclerosis
Phase 2B Study of Memantine for the Treatment of Amyotrophic Lateral Sclerosis
Enrollment Status: Completed
Publish Date: November 29, 2022
Intervention Type: Drug
Study Drug: Memantine
Study Phase: Phase 2
Duchenne Muscular Dystrophy: Double-blind Randomized Trial to Find Optimum Steroid Regimen
Duchenne Muscular Dystrophy: Double-blind Randomized Trial to Find Optimum Steroid Regimen
Enrollment Status: Completed
Publish Date: August 12, 2022
Intervention Type: Drug
Study Phase: Phase 3
Understanding Communication and Cognitive Impairments in Neurodegenerative Disorders
Understanding Communication and Cognitive Impairments in Neurodegenerative Disorders
Enrollment Status: Completed
Publish Date: May 17, 2022
Intervention Type: Behavioral
Study Phase: Not Applicable
An Open-Label, Multi-Center, Study With a Concurrent Untreated Control Arm to Evaluate the Efficacy and Safety of Eteplirsen in Duchenne Muscular Dystrophy
An Open-Label, Multi-Center, Study With a Concurrent Untreated Control Arm to Evaluate the Efficacy and Safety of Eteplirsen in Duchenne Muscular Dystrophy
Enrollment Status: Completed
Publish Date: January 25, 2021
Intervention Type: Drug
Study Phase: Phase 3
Tocilizumab in the Treatment of Refractory Polymyositis and Dermatomyositis
Tocilizumab in the Treatment of Refractory Polymyositis and Dermatomyositis
Enrollment Status: Completed
Publish Date: October 30, 2020
Intervention Type: Drug
Study Phase: Phase 2
A Phase 2 Randomized, Placebo Controlled Trial of Tocilizumab in ALS Subjects
A Phase 2 Randomized, Placebo Controlled Trial of Tocilizumab in ALS Subjects
Enrollment Status: Completed
Publish Date: December 18, 2019
Intervention Type: Drug, Other
Study Phase: Phase 2
A Phase 2 Randomized, Double-Blind, Placebo-Controlled, Multicenter Study of NP001 in Subjects With Amyotrophic Lateral Sclerosis (ALS) and Evidence of Elevated Systemic Inflammation
A Phase 2 Randomized, Double-Blind, Placebo-Controlled, Multicenter Study of NP001 in Subjects With Amyotrophic Lateral Sclerosis (ALS) and Evidence of Elevated Systemic Inflammation
Enrollment Status: Completed
Publish Date: May 07, 2018
Intervention Type: Drug
Study Phase: Phase 2
A Multicenter Observational Study to Assess the Variability of Molecular Biomarkers and Clinical Measures in Patients With Myotonic Dystrophy Type 1
A Multicenter Observational Study to Assess the Variability of Molecular Biomarkers and Clinical Measures in Patients With Myotonic Dystrophy Type 1
Enrollment Status: Completed
Publish Date: October 26, 2017
View 8 Less Clinical Trials

175 Total Publications

Recurrent neural networks and attention scores for personalized prediction and interpretation of patient-reported outcomes.
Recurrent neural networks and attention scores for personalized prediction and interpretation of patient-reported outcomes.
Journal: Journal of biopharmaceutical statistics
Published: March 13, 2025
Similar Doctors
Expertise in
12
conditions
Dr. Brandi R. French
Neurology
Expertise in
12
conditions
Dr. Brandi R. French
Neurology

The Curators Of The University Of Missouri

1020 Hitt St, 
Columbia, MO 
 (0.1 miles away)
Languages Spoken:
English
See accepted insurances
Accepting New Patients

Brandi French is a Neurologist in Columbia, Missouri. Dr. French is highly rated in 12 conditions, according to our data. Her top areas of expertise are Stroke, Transient Ischemic Attack (TIA), Cerebral Arteriovenous Malformation, Stent Placement, and Thrombectomy. Dr. French is currently accepting new patients.

Expertise in
23
conditions
Dr. Syed A. Shah
Neurology
Expertise in
23
conditions
Dr. Syed A. Shah
Neurology

The Curators Of The University Of Missouri

1020 Hitt St, 
Columbia, MO 
 (0.1 miles away)
573-882-7129
Languages Spoken:
English
See accepted insurances
Accepting New Patients

Syed Shah is a Neurologist in Columbia, Missouri. Dr. Shah is highly rated in 23 conditions, according to our data. His top areas of expertise are Familial Paroxysmal Nonkinesigenic Dyskinesia, Dopa-Responsive Dystonia, Aromatic L-Amino Acid Decarboxylase (AADC) Deficiency, and Drug Induced Dyskinesia. Dr. Shah is currently accepting new patients.

Expertise in
15
conditions
Dr. Farhan Siddiq
Neurosurgery | Neurology
Expertise in
15
conditions
Dr. Farhan Siddiq
Neurosurgery | Neurology

The Curators Of The University Of Missouri

1 Hospital Dr, 
Columbia, MO 
 (0.1 miles away)
573-882-4141
Languages Spoken:
English, Hindi, Punjabi, Urdu
See accepted insurances
Accepting New Patients

Farhan Siddiq is a Neurosurgery specialist and a Neurologist in Columbia, Missouri. Dr. Siddiq is highly rated in 15 conditions, according to our data. His top areas of expertise are Stroke, Subarachnoid Hemorrhage, Subdural Hematoma, Stent Placement, and Angioplasty. Dr. Siddiq is currently accepting new patients.

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Dr. Barohn's expertise for a condition
ConditionClose
View All 10 Advanced Conditions
View All 50 Experienced Conditions
Want to save this doctor for later?
Sign Up
Is this your doctor?
Find A Second Opinion
Not sure about your diagnosis?
Check Your Symptoms
 
 
 
 
Learn about our expert tiers
Learn More
Are you the provider on this profile?
Claim Profile